Dr. Bill Brashier provides astute knowledge and understanding of clinical research, statistical methods and cell biology, which is very unique combination amongst medical professionals globally. He is a qualified Chest specialist with training in Cell biology from the National heart and Lung Institute, Imperial College, London, UK.

Prior to this assignment, Dr. Brashier was the Head of Academic Clinical and Cell biology Research at one of the premier respiratory Research Institutes; the Chest Research Foundation in Pune, India. He was also the Principal Coordinating Investigator for stem cell clinical trials conducted under Regenetek Therapies, India.

He has been instrumental in procuring grants, initiating international research collaboration and directing high-level research in India. He has been a mentor to various PhD and MD students in his country and globally. He has single handedly founded the Cell biology Unit at the Chest Research Foundation, Pune, India. He has been involved with stem cell research with Regenetek Therapies India and has been involved in autologous stem cell separation and implantation in patients with neuro-degenerative diseases. He has been a recipient of the prestigious “European Respiratory fellowship”, and has received the “Best Research Award” by the European Respiratory Society at Stockholm in 2007.

He is part of the consulting panels of leading pharmaceutical companies in India such as Cipla and Glenmark. He has authored several book chapters especially on disease mechanisms of inflammatory diseases, and various publications in peer reviewed high impact Journals such as the New England Journal of Medicine. He is also in the body of reviewers for various international scientific journals. He has been implemental in training doctors on disease Mechanisms in India, Sri Lanka, Kenya and the Middle East.

Dr. Brashier has also held position as Chairman of the Independent Ethic Committee Pune (the IECP), which is registered with Government of India and Department of Health and Human Services, NIH, USA and had been involved in ethical regulation of various International clinical and bioequivalence drug trials.